EUVIMEDEUVIMED entdecken
Crossref

Inhibitory activity of psilocybin/psilocin towards the enzymes of the cytochrome P450 (CYP450): an in vitro evaluation

Brito-Da-Costa, A. M., Silva-Carvalho, M., Ricardo Jorge Dinis‐Oliveira, Madureira-Carvalho, Á., Diana Dias da Silva

Science Letters · 15.04.2023

DOI: 10.48797/sl.2023.63 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 15.04.2023. Verfasst von Brito-Da-Costa und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psilocybin is a hallucinogen produced by several “magic mushrooms” [1,2]. This prodrug is rapidly metabolized in the organism by alkaline phosphatases and esterases into psilocin, the active drug [1,2]. A scientific gap exists regarding the possible interactions between psilocybin/psilocin and CYP450 enzymes. Since the binding of drugs to CYP450 enzymes can interfere with the metabolism of other substrates leading to drug-drug interactions, this research topic is of utmost importance.

Objective

This study aimed to assess potential inhibitory interactions between psilocybin/psilocin and CYP3A4, 2D6, 2B6 and 2A6.

Methods

The in vitro assessment of CYP450 inhibition was performed using the Vivid®CYP450 screening kits, following the user’s guide. Concentrations of psilocybin and psilocin ranged between 1.14´10-13 - 4 mM and 6.1´10-5 - 1 mM for CYP3A4; 1.71´10-13 - 8 mM and 6.1´10-5 - 1 mM for CYP2D6; 2.4´10-4 - 8 mM and 2.4´10-5 - 1 mM for CYP2B6; and 3.8´10-6 - 2 mM and 7.6´10-8 - 1 mM for CYP2A6, respectively. Each test condition was mixed with baculosomes expressing the specific CYP, Vivid® regeneration system, NADP+, and a non-fluorescent substrate. Solvent and positive controls of inhibition, i.e., ketoconazole (CYP3A4), quinidine (CYP2D6), miconazole (CYP2B6) and tranylcypromine (CYP2A6,) were included. Fluorescence was measured for 60 minutes (Ex=415/20nm; Em=460/20nm) and the half-maximal inhibitory concentration (IC50) calculated using GraphPad prism 9.3.0. For CYP3A4 and 2D6 a minimum of three independent experiments were performed, and two independent experiments for CYP2A6 and 2B6.

Results

For psilocybin, IC50 values of 49.43 mM (CYP3A4), >1000 mM (CYP2D6 and 2B6), and >300 mM (CYP2A6) were attained. For psilocin, the following IC50 values were obtained: 2.12 mM (CYP3A4), 11.89 mM (CYP2D6), 0.99 mM (CYP2A6) and 4.05 mM (CYP2B6).

Conclusions

The results suggest a potential for psilocin to be an inhibitor of all the enzymes evaluated, especially CYP2A6, contrary to psilocybin which seems to only have the potential to inhibit CYP3A4.

Schlagwörter

psilocybinpsilocincytochrome P450 inhibitiondrug-drug interactionsCYP3A4CYP2D6CYP2B6CYP2A6hallucinogensmagic mushrooms

Zitieren

APA

Brito-Da-Costa, M., A., Silva-Carvalho, M., Dinis‐Oliveira, R. J., Madureira-Carvalho, Á., & Silva, D. D. D. (2023). Inhibitory activity of psilocybin/psilocin towards the enzymes of the cytochrome P450 (CYP450): an in vitro evaluation. Science Letters. https://doi.org/10.48797/sl.2023.63

Vancouver

Brito-Da-Costa, M. A, Silva-Carvalho, M., Dinis‐Oliveira RJ, Madureira-Carvalho, et al. Inhibitory activity of psilocybin/psilocin towards the enzymes of the cytochrome P450 (CYP450): an in vitro evaluation. Science Letters. 2023. doi:10.48797/sl.2023.63

BibTeX
@article{BritoDaCosta2023,
  author = {Brito-Da-Costa and M., A. and Silva-Carvalho and M. and Dinis‐Oliveira, Ricardo Jorge and Madureira-Carvalho and Á. and Silva, Diana Dias da},
  title = {Inhibitory activity of psilocybin/psilocin towards the enzymes of the cytochrome P450 (CYP450): an in vitro evaluation},
  journal = {Science Letters},
  year = {2023},
  doi = {10.48797/sl.2023.63}
}
Kostenlos starten →